Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway

Overview of attention for article published in OncoTargets and therapy, October 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 18,021 followers.

'Emodin Reverses Gemcitabine Resistance of #PancreaticCancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway' an article on #ScienceOpen: https://t.co/coybCMKhxC #OpenAccess #OAWeek @DovePress #oncotarget

Reply Repost Favourite